In resolving this issue, the International Ki67 in Breast Cancer Working Group (IKWG) agrees that without improvements in the standardisation of the Ki-67 cut-off value, routine, non-trial settings can reliably categorise very low Ki-67 as ≤5% and very high as ≥30% [145]. This evidence concerns the gene MKI67 and breast cancer.